Try our Advanced Search for more refined results

Valeant Says Stomach Ulcer Drug Is Being Imported Unfairly

By Tiffany Hu (February 23, 2018, 4:50 PM EST) -- Valeant Pharmaceuticals Inc. filed a claim with the U.S. International Trade Commission alleging that three American companies sold in the U.S. "falsely and misleadingly labeled" drugs containing clidinium bromide that purported to be generic versions of Valeant's stomach ulcer drug Librax, in violation of the Tariff Act of 1930....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!